1 21 4

Shareholder Tools

Home Investor Relations Press Releases

Press Releases

All Releases
View Summary MacroGenics Initiates Phase 1 Study of MGD010 for the Treatment of Autoimmune Disorders
Mar 16, 2015
PDF 14.7 KB Add to Briefcase
View Summary MacroGenics Provides Update on Corporate Progress and 2014 Financial Results
Mar 3, 2015
PDF 24.0 KB Add to Briefcase
View Summary MacroGenics to Present at the Roth Capital Partners 27th Annual Growth Stock Conference
Mar 2, 2015
PDF 12.4 KB Add to Briefcase
View Summary MacroGenics Announces Date of Fourth Quarter and Full Year 2014 Financial Results Conference Call
Feb 24, 2015
PDF 10.5 KB Add to Briefcase
View Summary MacroGenics to Present at the Leerink Global Healthcare Conference
Feb 5, 2015
PDF 12.4 KB Add to Briefcase
View Summary MacroGenics Announces Closing of Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
Jan 27, 2015
PDF 12.8 KB Add to Briefcase
View Summary MacroGenics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Jan 12, 2015
PDF 12.2 KB Add to Briefcase
View Summary MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
Dec 22, 2014
PDF 15.5 KB Add to Briefcase
View Summary MacroGenics Announces Presentation of Pre-clinical Data on new DART(r) Candidate MGD011 at 56th Annual Meeting of the American Society of Hematology
Dec 6, 2014
PDF 14.6 KB Add to Briefcase
View Summary MacroGenics to Present at the Oppenheimer 25th Annual Healthcare Conference
Dec 3, 2014
PDF 12.3 KB Add to Briefcase
View Summary MacroGenics to Present at the Stifel 2014 Healthcare Conference
Nov 12, 2014
PDF 12.5 KB Add to Briefcase
View Summary MacroGenics Provides Update on Corporate Progress and Third Quarter 2014 Financial Results
Nov 11, 2014
PDF 24.5 KB Add to Briefcase
View Summary MacroGenics Announces Pre-clinical Data to be Presented at ASH 2014 Annual Meeting
Nov 6, 2014
PDF 13.8 KB Add to Briefcase
View Summary MacroGenics to Present Pre-Clinical Data on MGD006 at 26th EORTC-NCI-AACR Symposium
Oct 30, 2014
PDF 14.5 KB Add to Briefcase
View Summary MacroGenics Announces Date of Third Quarter 2014 Financial Results Conference Call
Oct 28, 2014
PDF 10.4 KB Add to Briefcase
View Summary MacroGenics and Takeda Enter Second Strategic Alliance to Develop Multiple Additional DART Therapeutics
Sep 29, 2014
PDF 17.2 KB Add to Briefcase
View Summary MacroGenics to Present at the Wedbush 2014 Life Sciences Management Access Conference
Aug 6, 2014
PDF 11.8 KB Add to Briefcase
View Summary MacroGenics Provides Update on Corporate Progress and Second Quarter 2014 Financial Results
Aug 5, 2014
PDF 22.8 KB Add to Briefcase
View Summary MacroGenics Announces Date of Second Quarter 2014 Financial Results Conference Call
Jul 29, 2014
PDF 10.3 KB Add to Briefcase
View Summary MacroGenics' DART Candidate IND for Colorectal Cancer, MGD007, Cleared to Start Enrolling Patients
Jul 24, 2014
PDF 13.3 KB Add to Briefcase
Showing 1-20 of 93 Page: 1 2 3 4 5  Next 20
Add to Briefcase = add release to Briefcase